Medical Devices Startups

Permobil manufactures mobility and seating solutions, including the ROHO QUADTRO SELECT pressure-relieving cushion system, for individuals with mobility limitations or wheelchair users.

1 investor

Perseo Pharma is a biotech spin-off from the University of Applied Sciences in Basel, Switzerland, developing enzyme immobilization and bioconjugation technologies for therapeutic applications. The company focuses on creating novel platforms for drug delivery and enzyme-based therapies targeting inborn errors of metabolism and other rare diseases.

1 investor

Parsian Tarava manufactures needle-style reusable electrodes for electroporation applications in gene transfer and drug delivery across in vivo, ex vivo, and in ovo conditions. The electrodes are designed for use in research, biomedical, genetic, and pharmaceutical settings.

1 investor

Perspectum develops digital medical technology and diagnostics using multiparametric MRI to assess and diagnose chronic systemic diseases including liver disease, long COVID, diabetes, and cancer for clinicians and patients.

1 investor

Perth Radiological Clinic is a private diagnostic imaging provider offering radiological services to the Western Australian community using advanced technology and trained medical professionals.

1 investor

Perthera provides an AI-powered precision medicine platform for oncologists that analyzes multi-omic molecular data and patient medical history to match cancer patients with targeted therapy options. The platform delivers clinical decision support and real-world evidence to guide personalized cancer treatment.

1 investor

Petrichor Capital Partners is a venture capital and private equity firm that invests in life sciences and biotech companies, with operations including a dedicated operating partner network and advisory board of scientific and medical experts.

1 investor

Peytant develops amnion-derived membrane coverings using human placental tissue to reduce the body's foreign body response in implants used for luminal disease treatment. The company's products are designed to increase patency and help clinicians manage vascular and other luminal conditions.

1 investor

Phanes Therapeutics develops oncology and metabolic disease therapeutics targeting cell cycle regulators and related pathways. The company operates from San Diego with operations including a research site in Shanghai.

1 investor

A contract drug manufacturing organization (CDMO) specializing in complex pharmaceutical formulations and potent compounds, serving drugmakers from small batches through full-scale production. The company holds FDA licensure and operates multiple manufacturing facilities with capabilities in oral dosage, aseptic processing, and analytical services.

1 investor

Pharmacierge receives electronic prescriptions from private clinicians and delivers medication directly to patients via same-day delivery across London and beyond. The company operates a robotically-enabled dispensary and provides an e-prescribing platform connecting independent private medical practices with pharmacy services.

1 investor

Pharmatest provides preclinical research services for drug development, including cell culture assays and animal models for cancer and skeletal disease research. The company serves pharmaceutical, biotechnology, and nutraceutical companies developing therapeutics and phytopharmaceutical products.

1 investor

PHASE Scientific develops diagnostic tools and technologies to improve health information accessibility and accuracy, with expertise in infectious disease prevention, dental health risk assessment, and bioengineering-based diagnostics.

1 investor

PHC Corporation manufactures life sciences and diagnostic equipment, including ultra-low temperature freezers, CO2 incubators, live cell metabolic analyzers, and point-of-care testing devices for research, medical, and cell/gene therapy applications.

1 investor

Phelcom offers Eyer2, a portable clinical-grade retinal camera that captures fundus and ocular surface images wirelessly from a handheld device for use in eye care practices. The device integrates with existing electronic health records systems and includes cloud storage capabilities for telemedicine workflows.

1 investor

Phenota develops automation technology for hematology laboratories, applying Raman spectroscopy to routine blood testing for real-time analysis. It targets clinical diagnostic labs with tools built around their workflow.

1 investor

Phi Optics develops quantitative phase imaging (QPI) technology that upgrades existing microscopes to enable non-invasive, real-time 3D imaging of live cells, tissues, organoids, and small organisms without labels or specimen damage. The technology serves research institutions and clinical laboratories in life sciences and diagnostics.

1 investor

Phibodent is an industrial manufacturer of dental restorations, producing CAD-CAM structures in chrome-cobalt and titanium as well as custom bite splints for dental laboratories and clinics. It also offers a cloud platform for digital prescription and management of dental treatments, with an international presence.

1 investor

Phicrobe develops rapid diagnostic tests for detecting E. coli O157:H7 using genetically modified bacteriophage technology that produces light in the presence of the pathogen. The technology enables pathogen detection without specialized equipment or expensive reagents for use in food safety and clinical testing applications.

1 investor

Philogen discovers and develops targeted anti-cancer biopharmaceutical drugs using monoclonal antibodies and small molecules for tumor-specific delivery. The company focuses on vascular targeting to deliver therapeutic agents to tumors while sparing healthy tissues.

1 investor

Phi Med Europe develops NerveCheck, a portable medical device for early diagnosis and quantification of peripheral neuropathy, particularly diabetic neuropathy, using quantitative sensory testing (QST) technology. The device delivers rapid, non-invasive assessment of small and medium nerve fiber function for healthcare professionals in clinical settings.

1 investor

Phlebot develops medical devices for blood collection and diagnostics, with a focus on pediatric and intensive care applications. The company is advising on intellectual property, regulatory, and legal services related to FDA compliance for life sciences products.

1 investor

Phoenix PharmaLabs is a pharmaceutical company that welcomes inquiries from organizations seeking business relationships and potential opportunities.

1 investor

Phoenix Kinetics develops the NUsurface meniscus implant, a device that preserves knee motion and provides pain relief for patients with early knee osteoarthritis who fall between meniscal allograft transplantation and total knee replacement. The company targets an estimated U.S. patient population of over one million and has run clinical trials demonstrating pain reduction and improved physical function.

1 investor